Some hospital-at-home alternative are entirely virtual, while others don't require patients to visit a hospital first.

Edwards Lifesciences Veteran Katie Szyman Named Next Masimo CEO. The Irvine-based medical device maker last week announced ...

Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie Szyman has been appointe ...

This page features the latest news about the Inari Med stock. Inari medical director William Hoffman sells $12.1 million in stock William Hoffman, a director at Inari Medical (TASE:PMCN), Inc ...

Inari Medical Inc., one of Orange County’s fastest-growing medical device makers, is being acquired for $4.9 billion by global medical technology company Stryker Corp. Stryker on Jan. 6 announced an ...

Visit the MedPage Today Information Center to learn more about how you can contribute as a physician or other healthcare provider. Visit us on Facebook. Opens in a new tab or window Visit us on X ...

We recently published an article titled These 10 Firms Led This Week's Rally. In this article, we are going to take a look at where Inari Medical Inc. (NASDAQ:NARI) stands against the other stocks.

90.98% of the stock is owned by institutional investors. Inari Medical, Inc builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific ...

Irvine-based Inari Medical Inc. will be acquired by Stryker Corp. for $4.8 billion. The boards of directors of both companies have approved the transaction, and it’s expected to close in the ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS ... novel catheter-based mechanical thrombectomy devices that are designed to remove large clots ...